Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: A case control study  by Shariff, Noorsuzana Mohd & Safian, Nazarudin
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 3 2 3 –3 2 9
.sc ienced i rec t .comHO ST E D  BY Avai lab le a t wwwScienceDirect
journal homepage: www.elsevier .com/ locate / IJMYCODiabetes mellitus and its influence on sputum
smear positivity at the 2nd month of treatment
among pulmonary tuberculosis patients in Kuala
Lumpur, Malaysia: A case control studyqhttp://dx.doi.org/10.1016/j.ijmyco.2015.09.003
2212-5531/ 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd. All rights reserved.
* Corresponding author at: Department of Community Medicine, Universiti Kebangsaan Malaysia Medical Center, Faculty of
Universiti Kebangsaan Malaysia, Jalan Yaakob Latiff, 56000 Kuala Lumpur, Malaysia.
E-mail address: suzana_1910@yahoo.com (N.M. Shariff).
Peer review under responsibility of Asian African Society for Mycobacteriology.Noorsuzana Mohd Shariff a,b,*, Nazarudin Safian b
a Infectious Disease Cluster, Advanced Medical and Dental Institute, University of Science Malaysia, Pulau Pinang, Malaysia
bDepartment of Community Health, National University of Malaysia Medical Center, Jalan Yaacob Latiff, Kuala Lumpur, MalaysiaA R T I C L E I N F O
Article history:
Received 11 August 2015
Received in revised form
3 September 2015
Accepted 6 September 2015
Available online 1 October 2015
Keywords:
Risk factors
Sputum smear nonconversion
TuberculosisA B S T R A C T
Objective/background: Many studies have suggested that sputum smear conversion after
2 months of antituberculosis treatment is an important determinant of treatment success
and can be a predictor for relapse. The objective of this study is to determine the factors
that influence sputum smear conversion after 2 months of treatment among pulmonary
tuberculosis patients receiving treatment in the Institute of Respiratory Medicine in Kuala
Lumpur, Malaysia.
Methods: A total of 75 cases and 75 controls were interviewed, and their medical records
were retrieved in order to extract the information needed. All analyses were conducted
using SPSS version 17, and binary logistic regression analysis was used to determine the
predictors of sputum smear nonconversion.
Results: Results showed that the following factors were associated with sputum smear pos-
itivity after 2 months of intensive treatment: diabetes mellitus (p = .013, odds ratio [OR]
= 2.59, 95% confidence interval [CI] 1.27–5.33), underweight body mass index (p = .025,
OR = 1.67, 95% CI 0.80–3.49), nonadherent to tuberculosis treatment (p = .024, OR = 2.85,
95% CI 1.21–6.74), and previous history of tuberculosis (p = .043, OR = 2.53, 95% CI
1.09–5.83). Multivariable analysis identified diabetes mellitus (p = .003, OR = 4.01, 95% CI
1.61–9.96) as being independently associated with the risk of persistent sputum smear pos-
itivity after 2 months of intensive treatment.
Conclusion: Based on the findings, identification of these factors is valuable in strengthen-
ing the management and treatment of tuberculosis in Malaysia in the future. This study
emphasizes the importance of diabetes screening and integration of diabetic controls
among tuberculosis patients in achieving better treatment outcome.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Medicine,
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An alarming current statistics by the World Health Organiza-
tion reported that three out of 10 deaths worldwide are due to
communicable diseases, which also account for 51% of Years
of Life Lost globally [1]. Unlike the successful story of small-
pox elimination, it seems that tuberculosis has made its
comeback and is becoming a re-emerging global public health
problem.
Sputum smear conversion among pulmonary tuberculosis
patients was said to be the most important indicator in eval-
uating the effectiveness of treatment provided to patients and
also the infectivity of the disease. In proving this, Holtz et al.
[2] carried out a retrospective cohort study on civilian tuber-
culosis patients with multidrug resistance in Latvia. Through
this study, they found that treatment outcomes were statisti-
cally significantly worse for patients who did not convert their
sputum positivity within 2 months of treatment [2]. This is
supported by Dembele et al. [3], who found that the cure rate
was higher among patients who were smear-negative at the
2nd month (77.3%) of follow-up. In response to this knowl-
edge, another researcher conducted studies looking into the
factors which can influence sputum smear conversion in
order to help improve and empower the current treatment
practice.
Among other developing countries, Malaysia has been
classified by the World Health Organization as an intermedi-
ate tuberculosis burden country. Recent statistics by the Dis-
ease Control Division of Ministry of Health Malaysia [4]
revealed that 17,506 new cases were registered in Malaysia
in the year 2008. Out of this big number, 10,441 cases were
infectious forms.
Even though the sputum conversion rate at the end of
2 months in Malaysia stayed above the targeted level (>85%),
in the year 2008, on average, 7.65% of the infectious tubercu-
losis patient reported delays in sputum conversion. This
increases the tendency of prolonged inactivity of the patient,
which later increases the risk of high secondary attack in the
community. As a consequence, it increases the national bur-
den due to increased incidence of tuberculosis.
Even though the factors influencing sputum smear conver-
sion have been studied well, however, to the best of our
knowledge, there have been no similar studies done in Malay-
sia. Findings from other international studies might not be
applicable to the Malaysian population as our cultural and
local practices differ.
Therefore, the aim of this study was to determine the fac-
tors that may influence the sputum smear conversion after
2 months of intensive treatment among pulmonary tubercu-
losis patients. In-depth understanding of factors that may
contribute to this phenomenon is crucial to combat poor
treatment outcome and further reduce the dynamic trans-
mission of tuberculosis in the community.
Materials and methods
This study was carried out as an unmatched case–control
study within June 2010 to September 2010.Study population
This study was conducted at the tuberculosis clinic at the
Institute of Respiratory Medicine (IPR), which is located at
Jalan Pahang, Kuala Lumpur, Malaysia. This institute provides
outpatient clinics (2 times/wk; Monday and Thursday) and
inpatient services to patient with tuberculosis, as well as
patients with other serious respiratory diseases.
The sampling population of this study was all smear-
positive pulmonary tuberculosis patients with persistence of
positivity after 2 monthsof intensive treatmentwho registered
at the IPR from December 2009 to June 2010. Purposive sam-
pling was applied in enrolling cases and controls in this study.
Patients were included as a case if they were initially diag-
nosed of smear-positive pulmonary tuberculosis with clinical
and/or bacteriological evidence, tested positive with micro-
scopic sputum smear investigation (at least 2 acid-fast bacilli
positive) at the end of the 2nd month of intensive antituber-
culosis treatment, aged P20 years, able to understand and
communicate wisely in Malay language, willing to participate
in the study, and had signed the consent form. However,
those who were initially diagnosed of smear-positive pul-
monary tuberculosis with clinical and/or bacteriological evi-
dence, and tested negative using microscopic sputum smear
investigation at the end of the 2nd month of intensive antitu-
berculosis treatment were included as controls for this study.
Thosewhowere not registeredwith the IPR, diagnosedwith
another formof tuberculosis suchas extra pulmonary tubercu-
losis, human immunodeficiency virus positive, pregnant
women, terminally ill at which restricting them to give full
cooperation, did not do their sputum smear examination after
2 months of intensive treatment with doubtful smear results,
or, unwilling to participate were excluded from this study.
Study instruments
Data was collected using three instruments: (1) structured
self-administered questionnaires; (2) patients’ records; and
(3) anthropometric measurements. The administered ques-
tionnaire was used to assess the participants sociodemo-
graphic information, treatment related factors, and their
smoking habit. Next, patients’ records were used to obtain
information regarding laboratory results of sputum smear
after 2 months of treatment of each participant, their diabetes
status, treatment regime, and adherence to treatment. As for
the anthropometric measurement, two scales, namely Seca
bellissima 841 digital weighing scale (with 0.1 kg level of
accuracy) and Seca bodymeter microtoidse tape (Seca
Medizinische Waagen und Messsysteme Vogel & Halke GmbH
& Co, Hamburg, Germany) (error of measurement of ±0.1 cm),
were used in measuring body weight and height, respectively.
Body mass index was calculated based on these two readings.
Data collection procedure
Before the researcher started to collect data from the respon-
dents, cases and controls were met during their follow-up;
which is on Monday or Thursday. The researcher approached
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tion regarding the study. Nothing was done before the
patients signed the consent form. After they agreed, each par-
ticipant’s body weight and height were measured following
the standardized technique. Measurements were carried out
by the researcher herself. During the measurements, the par-
ticipant was asked to wear light clothes, no shoes, and to
stand straight with both hands at the body side. In order to
avoid measurement bias, readings were taken twice and only
the average was used. The body mass index was classified
according to clinical practice guidelines on the management
of obesity, Ministry of Health Malaysia (2004) [5]. Next, the
researcher gave a set of questions to be answered by the par-
ticipants. This was a self-administered questionnaire and
each of the patients were given about 10 min to answer all
the questions with researcher supervision.
Statistical analysis
Data were entered and analyzed by using the SPSS version
17.0 for Windows (SPSS Inc., Chicago, IL, USA). Data were pre-
sented as descriptive statistics either as mean, median, stan-
dard deviation, frequencies, or percentages. Differences and
associations between categorical variables were analyzed
using chi-square test. Student t test or Mann–Whitney U test
(for data which were not normally distributed) were used to
compare the differences in means of continuous variables.
Multiple logistic regressions with forward stepwise strategy
was used in assessing the association between the risk fac-
tors (independent variables) and the outcome of sputum
smear conversion after 2 months of intensive treatment, sta-
tistically adjusted for potential confounding effects of other
covariates. A p value <.05 was used as the level of significance.
Ethical considerations
This study was conducted on a voluntary basis whereby every
patient has their own right to participate or withdraw from
the study. Oral andwritten information in BahasaMelayuwere
provided to all participants prior to obtaining informed oral
and written consent. All data were kept confidential for aca-
demicpurposesonly.Also, ethical approval and formalpermis-
sion was obtained from the Ethical Committee of Universiti
Kebangsaan Malaysia, Faculty of Medicine, Kuala Lumpur,
Malaysia and the director of IPR, accordingly. This study was
also registeredwith the National Malaysian Research Registry.
Results
During the study period, a total of 150 smear-positive pul-
monary tuberculosis patients were recruited into the study.
With ratio of cases to controls was 1:1, and 75 of them were
analyzed as cases and the rest were represented as controls.
One-hundred and fifty eligible patients were approached dur-
ing their follow-up and 100% of the patients were willing to
participate and give a positive response towards the study.
Among 150 patients recruited in this study, cases were
found to be slightly older compared with the controls,
with a mean of age 45 ± 11.33 years and 43 ± 14.79 years,respectively. The range of ages was between 20 years and
76 years. More men were seen among the cases (79%) com-
pared with only 67% among controls. In terms of ethnicity,
more than half of the respondents were Malay. Furthermore,
most of them were married.
On bivariable analysis, it was found that those patients
who did not adhere to their treatment had three times higher
odds of having sputum smear nonconversion after 2 months
of intensive treatment compared with those religiously taking
their drugs (odds ratio [OR] = 2.85, 95% confidence interval [CI]
1.21–6.74). Moreover, patients with a history of previous
tuberculosis treatment had three times higher odds of having
sputum smear nonconversion after 2 months of intensive
treatment compared with new cases. However, the other
sociodemographic characteristics have no significant influ-
ence on sputum smear conversion in this study (Table 1).
With regards to patients’ smoking habit, no significant
associations were seen between smoking status and sputum
smear conversion in this current study (Table 2).
Next, bivariable analysis on the relationship between dia-
betes mellitus and sputum smear conversion after 2 months
of antitreatment revealed an interesting finding. This study
showed that diabetes mellitus was significantly associated
with delays in sputum smear conversion after the intensive
treatment. Patients who are smear-positive pulmonary tuber-
culosis with the presence of diabetes mellitus had 2.6 times
higher odds of having sputum smear nonconversion com-
pared with those without this metabolic deficiency
(OR = 2.59, 95% CI 1.27–5.33).
Furthermore, body mass index was shown to be signifi-
cantly associated with sputum smear nonconversion after
2 months of tuberculosis treatment (p = .025). Being under-
weight and obese were proven to be a causative factor
towards sputum smear nonconversion compared with those
with an ideal body weight (OR = 1.67, 95% CI 0.80–3.49 and
OR = 1.77, 95% CI 0.39–8.06, respectively; Table 3).
Further analysis usingmultiple logistic regression was per-
formed to determined factors that are independently associ-
ated with sputum smear-positivity after 2 months of
intensive treatment. All of the variables that were found to
be significant on the bivariable analyses (p < .05) were entered
into the multiple logistic regression model using forward
stepwise strategy.
The final multiple binary logistic regression model showed
that, diabetes mellitus remained to be an independent causa-
tive factor of sputum smear nonconversion after 2 months of
intensive treatment. Finding showed that, patients with dia-
betes mellitus were four times more likely to be nonconverted
comparedwith thosewithout diabetesmellitus (OR = 4.00, 95%
CI 1.61–9.96). After adjusting for confounders and interactions,
adherence to treatment, history of tuberculosis treatment, and
body mass index were no longer significantly associated with
the 2nd month sputum smear conversion and were excluded
from the final prediction model (p > .05) (Table 4).
Discussion
In this study, the mean age for both patients in the case group
and control group was found to be around the middle adult
Table 1 – Association between sociodemographic characteristics of cases and controls and sputum smear conversion after
intensive treatment.
Characteristics Cases (n = 75) Control (n = 75) X2a p Crude ORb (95% CI)
n % n %
Sex
Women 16 21.3 25 33.0 2.72 .099 Reference
1.84 (0.89–3.83)Men 59 78.7 50 66.7
Marital status
Single 21 28.0 31 41.3 2.94 .086 Reference
1.81 (0.92–3.58)Married 54 72.0 44 58.7
Occupation
Laborer 33 44.0 38 50.7 0.74 .690 Reference
1.42 (0.59–3.38)
1.25 (0.60–2.58)
White-collared 16 21.3 13 17.3
Unemployed 26 34.7 24 32.0
Ethnicity
Malay 40 53.3 42 56.0 6.32 .097 Reference
0.58 (0.25–1.36)
1.63 (0.64–4.19)
2.63 (0.76–9.05)
Chinese 11 14.7 20 26.7
Indian 14 18.7 9 12.0
Other 10 13.3 4 5.3
Education level
Primary 23 30.7 24 32.0 2.14 .343 1.59 (0.59–4.36)
1.99 (0.78–5.08)
Refere nce
Secondary 43 57.3 36 48.0
Tertiary 9 12.0 15 20.0
Adherence to treatment
Yes 54 72.0 66 88.0 6.00 .024 Reference
2.85 (1.21–6.74)No 21 28.0 9 12.0
History of TB treatment
Yes 21 28.0 10 13.3 4.92 .043 2.53 (1.09–5.83)
ReferenceNo 54 72.0 65 86.7
Note: CI = confidence interval; OR = odds ratio; TB = tuberculosis.
a Pearson Chi-Square test was performed.
b Univariate binary logistic regression was performed.
Table 2 – Association between smoking and sputum smear conversion after intensive treatment among cases and control
(N = 75).
Cases (n = 75) Controls (n = 75) X2a p Crude OR (95% CI)b
n % n %
Smoking
Current smokers 40 53.3 35 46.7 1.42 .493 1.46 (0.73–2.92)
1.60 (0.55–4.65)
Reference
Former smokers 10 13.3 8 10.7
Nonsmokers 25 33.3 32 42.7
No. of cigarette/d (n = 75)
6 10 13 32.5 16 45.7 1.43 .488 Reference
1.85 (0.66–5.19)
1.58 (0.46–5.41)
11–20 18 45.0 12 34.3
>20 9 22.5 7 20.0
Pack y (n = 75)
6 10 13 32.5 12 34.3 .03 .985 Reference
1.06 (0.29–3.80)
1.09 (0.39–3.07)
11–20 8 20.0 7 20.0
>20 19 47.5 16 45.7
Note: CI = confidence interval; OR = odds ratio; y = year.
a Pearson Chi-Square was performed.
b Univariate binary logistic regression was performed.
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found to be older compared with other prior studies con-
ducted in Saudi Arabia. Singla et al. [6], in their study to pre-dict persistent of sputum smear-positivity among Saudi
Arabian pulmonary tuberculosis patients 2 months after
treatment, showed that the mean age of their patients was
Table 3 – Association between diabetes mellitus, body mass index, and sputum smear conversion after 2 months of
treatment among cases and controls (N = 150).
Cases (n = 75) Controls (n = 75) X2 p Crude ORc (95% CI)
n % n %
Diabetes statusa
Diabetic 31 41.3 6 21.3 6.97 .013 2.59 (1.27–5.33)
ReferenceNondiabetic 44 58.7 59 78.7
Body mass indexb
Underweight 33 44.0 21 28.0 9.24 .025 1.67 (0.80–3.49)
Reference
0.36 (0.13–1.01)
1.77 (0.39–8.06)
Ideal weight 31 41.3 33 44.0
Overweight 6 8.0 18 24.0
Obese 55 6.7 33 4.0
Note: CI = confidence interval; OR = odds ratio.
a Pearson Chi-Square test was performed.
b Fisher’s exact test was performed.
c Univariate binary logistic regression was perfomed.
Table 4 – Multiple binary logistic regression model of factors influencing sputum smear conversion after 2 months of
treatment (N = 150).
Factors B S.E Wald p Adjusted OR (95% CI)
Diabetes mellitus 1.39 0.46 8.94 .003* 4.01 (1.61–9.96)
Body mass index 7.51 .057
Underweight 0.60 0.42 2.05 .152 1.83 (0.80–4.18)
Overweight 1.10 0.58 3.64 .056 0.33 (0.10–1.03)
Obese 0.19 0.85 0.05 .820 0.83 (0.16–4.33)
Note: CI = confidence interval; OR = odds ratio; S.E = standard error.
* p < .05.
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found to be slightly older compared with patients in the con-
trol group [6]. This pattern is paralleled with another study
which showed that old age and those older than 60 years were
at a higher risk of sputum smear delay [7].
No significant association was seen between sex and spu-
tum smear conversion at the end of intensive antituberculo-
sis treatment. This finding was coherent with the study by
Pajankar et al. [8] in 2008. However, many other studies have
suggested an association between sex and outcome of spu-
tum smear conversion after the intensive phase. As an exam-
ple, Banu Rekha et al. [9] and Singla et al. [10], in their study
among pulmonary tuberculosis patients showed that being
male was associated with a lack of sputum smear conversion
at the end of the intensive phase. Most commonly, the expla-
nations given by other researchers to explain the reason why
men were more likely to experience a delay in sputum smear
conversion after the intensive treatment compared with
women were related to smoking and alcohol consumption.
With statistical analysis, this recent study showed no sig-
nificant association between other sociodemographic deter-
minants such as marital status, level of education,
occupation, and monthly income with the sputum smear
conversion after intensive phase. This finding was in agree-
ment with another comparative cross-sectional study done
by Kassam et al. [11], which showed that no significant differ-
ence in cure rates were seen between patients with high and
low incomes. However, some of these determinants werefound to be more frequent among those who were not spu-
tum smear converted compared with the controls. For
instance, we observed that patients engaged in a white col-
lared occupation were more likely to be nonconverted com-
pared with those who were laborers. This recent finding
contradicts an earlier study done 9 years ago in Uganda. That
study showed that subsistence farmers were 4.63-fold more
likely to have retreatment tuberculosis compared with unem-
ployed patients [12].
This recent study showed no statistically significant asso-
ciation between smoking and sputum smear conversion at
the end of the intensive treatment. This study suggests that
smokers and nonsmokers converted with almost the same
rate to a negative sputum status. The finding was supported
by the two other prior studies [13,14]. However, a study by
Metanat et al. [15] suggested a different finding, saying that
there was a significant delay in sputum smear conversion
time between smokers and nonsmokers, which is contrary
to the present study.
Next, the results of this study showed that patients with
diabetes mellitus were three times more likely to have spu-
tum smear nonconversion at the end of intensive treatment
compared with those without this metabolic deficiency. This
positive association was increased up to four times after con-
trolling for other risk factors in the multivariable analysis.
Findings of this study are in-line with four other different
studies conducted among pulmonary tuberculosis patients
in Indonesia, China, Saudi Arabia, and India. All of these
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patients’ sputum smear conversion after 2 months of tuber-
culosis treatment [16–19]. However, the finding of this recent
study is in contrary with another case control study which
showed no significant effect of diabetes on the sputum smear
positivity after 2 months of treatment [20]. In explaining this,
we have to look into the pathophysiology of diabetes and its
relation to general body function. Bashar et al. [21] provides
us with the answer by suggesting that diabetic patients have
some degree of impaired gastrointestinal drug absorption,
even in the absence of clinical gastroparesis. Not only that,
the hyperglycaemic state may additionally interfere with
achieving adequate tissue levels of the medications, or inter-
fere with alveolar macrophage or CD4+ cell function [21].
At the end of the study, we found that pulmonary tubercu-
losis patients who were underweight or obese were two times
more likely to be nonconverted compared with those with an
ideal body mass index. This finding was in agreement with
another international study conducted by Khan et al. [22].
These group of researchers provided a more clear direction
regardingbodymass index and tuberculosis outcomeby show-
ing that those pulmonary tuberculosis patients who had >5%
weight gain during the intensive phase of therapy had a lower
relapse risk compared with those who gained 65% [22].
The possible explanation would be that tuberculosis has a
well-known negative effect on patients nutritional status by
affecting dietary intake due to loss of appetite, poor absorp-
tion of nutrients from the intestine, and increase uptake of
nutrients by specific target tissue due to the increase of body
metabolism. Moreover, severe malnutrition has a profound
effect on cell-mediated immunity [23].
Our study showed that patients with poor adherence to
antituberculosis treatment during the intensive treatment
were three times more likely to experience sputum noncon-
version compared with those who religiously taking their
drugs. This finding was in parallel to the result obtained by
Thomas et al. [24], which suggested that patients who took
treatment irregularly were 2.6 times more likely to have
relapse than those who were adherent [24]. Similarly, in other
setting, Burman et al. [25] showed that noncompliant patients
had 9.9 times more risk of poor outcomes from the initial
course of therapy more often than compliant patients.
Another treatment related factor observed in this recent
study was the association between previous history of tuber-
culosis treatment and sputum smear conversion after the
intensive treatment. In this study, significant association
between the two factors was observed. Patients with previous
history of tuberculosis treatment were found to be three
times more likely to have sputum smear nonconversion com-
pared with those without previous exposure to tuberculosis.
This finding was supported by Singla et al. [6] and Fortun
et al. [26] who projected that factors significantly related to
a delay in smear conversion to negative were previous admin-
istration of antituberculosis drugs (therapy or prophylaxis).
This is possibly due to a previous infection which may
induce the presence of initial cavitations and increase the
extent of residual lesions of the lung. Cavitations have been
shown to be significantly associated with prolonged time-to-
smear conversion among pulmonary tuberculosis treatment[7]. However, Telzak et al. [27] disagrees with this finding by
showing that no prior history of tuberculosis was the factor
independently associated with an increased number of days
for both smear and culture conversion.
Despite all the encouraging findings found in this recent
study, there are several limitations that were faced by the
researcher during the study process, such as a small number
of samples, effect of study location, and the efficacy of docu-
mentation in the patients’ registry. These limitations should
be considered wisely before an interpretation of the study
findings could be made.
In conclusion, sputum smear conversion after the inten-
sive antituberculosis treatment was found to be significantly
related to diabetes in this study. Therefore, it is hoped that
the results of this study will be utilized to improve the plan-
ning and implementation of tuberculosis treatment by over-
coming the problems regarding delay in sputum smear
conversion. Patients should be consulted on healthy eating
and the importance of diabetic control. Future research in this
area should proceed with a cohort study focusing on a bigger
diversity of other factors such as radiological, microbiological,
and genetic contributions.
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